GO:0140115 export across plasma membrane: Cellular Efflux Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0140115 export across plasma membrane describes the directed movement of substances from inside a cell across the plasma membrane into the extracellular region.
• This process is essential for nutrient acquisition, waste removal, toxin resistance, and intercellular communication in both prokaryotes and eukaryotes.
• Multiple transport systems, including ATP-binding cassette (ABC) transporters, major facilitator superfamily (MFS) proteins, and dedicated secretion systems, mediate export across the plasma membrane.
• In mammalian cells, unconventional protein secretion allows leaderless proteins to exit the cell without passing through the classical ER-Golgi pathway.
• Dysregulation of export across the plasma membrane contributes to multidrug resistance in cancer and infectious diseases, as well as to lysosomal storage disorders and metabolic diseases.
• CRISPR-based knockout, knock-in, and overexpression models are powerful tools to dissect the molecular players and regulatory networks controlling export across the plasma membrane.
Description
Export across plasma membrane (GO:0140115) is a fundamental biological process that enables cells to release a wide variety of substances, including proteins, metabolites, ions, and xenobiotics, into the extracellular environment. This process is critical for cellular homeostasis, nutrient uptake, detoxification, and cell-to-cell communication. In bacteria, export systems are essential for the secretion of virulence factors and for the efflux of antibiotics, contributing to antimicrobial resistance. In eukaryotic cells, export across the plasma membrane is mediated by a diverse array of transporters and channels, and its dysfunction is linked to numerous human diseases, including cancer, neurodegeneration, and metabolic disorders. Understanding the molecular mechanisms, regulation, and physiological roles of export across the plasma membrane is therefore of paramount importance for basic biology and therapeutic development. This article provides a comprehensive overview of GO:0140115, integrating authoritative QuickGO data with insights from real PubMed literature, and highlights how CRISPR-based models can accelerate research in this field.
export across plasma membrane At A Glance
| GO ID | GO:0140115 |
|---|---|
| GO term | export across plasma membrane |
| Ontology | biological_process |
| Synonym | efflux |
| Definition | The directed movement of some substance from inside of a cell, across the plasma membrane and into the extracellular region. |
| Major function | Transport of proteins, metabolites, ions, and xenobiotics out of the cell |
| Related cellular components | Plasma membrane, transport vesicles, secretion systems |
| Related molecular functions | Transporter activity, ATPase activity, channel activity |
| Taxonomic scope | Bacteria, archaea, eukaryotes |
What Is GO:0140115?
According to the Gene Ontology, export across plasma membrane (GO:0140115) is defined as the directed movement of some substance from inside of a cell, across the plasma membrane and into the extracellular region. This process encompasses the active or passive translocation of molecules, such as proteins, metabolites, ions, and drugs, from the cytoplasm or other intracellular compartments to the outside of the cell. It is synonymous with efflux and is distinct from intracellular transport or vesicle-mediated secretion that bypasses the plasma membrane directly.
Why Is export across plasma membrane Important in Cell Biology?
Export across plasma membrane is vital for cellular survival and adaptation. It allows cells to acquire nutrients, expel toxic compounds, and communicate with their environment. In pathogenic bacteria, export systems are key virulence determinants and contribute to antibiotic resistance. In humans, defects in export pathways cause diseases such as lysosomal storage disorders and are implicated in cancer multidrug resistance. Moreover, export across the plasma membrane is essential for the release of signaling molecules, including cytokines and growth factors, that regulate immune responses and tissue homeostasis. Thus, studying this process offers insights into fundamental biology and provides targets for therapeutic intervention.
• Enables nutrient acquisition and waste removal in all domains of life.
• Mediates secretion of virulence factors and toxins in pathogenic bacteria.
• Contributes to multidrug resistance in cancer cells and pathogens.
• Facilitates unconventional protein secretion in mammalian cells.
• Regulates intercellular communication via release of signaling molecules.
• Maintains lysosomal homeostasis by exporting metabolites.
• Involved in transport of hydrophobic molecules across yeast plasma membrane.
• Dysfunction linked to metabolic disorders and neurodegeneration.
• Target for drug development to overcome resistance.
• Provides a model for studying membrane protein structure and function.
What Happens During export across plasma membrane?
Substrate Recognition and Binding
In simple terms: The cell identifies the substance to be exported and binds it to a transporter protein.
Export across the plasma membrane begins with the recognition of a specific substrate by a membrane-embedded transporter or channel. In bacteria, outer membrane transporters such as those in the TolC family recognize a wide range of substrates, including antibiotics and proteins. In eukaryotic cells, ATP-binding cassette (ABC) transporters and solute carriers (SLCs) bind substrates with varying specificity. The binding affinity and specificity are determined by the transporter's structure and regulatory domains.
Translocation Across the Membrane
In simple terms: The transporter moves the substance through the membrane barrier to the outside.
Once bound, the substrate is translocated across the lipid bilayer. This step often requires energy, either from ATP hydrolysis (as in ABC transporters) or from ion gradients (as in secondary active transporters). In Gram-negative bacteria, dedicated secretion systems, such as the type I, III, and VI secretion systems, span both inner and outer membranes to deliver substrates directly to the extracellular milieu. In mammalian cells, unconventional secretion pathways can mediate direct translocation of leaderless proteins across the plasma membrane.
Release and Recycling
In simple terms: The substance is released outside, and the transporter resets for another round.
After translocation, the substrate is released into the extracellular space. The transporter undergoes conformational changes to return to its initial state, ready for another cycle. In some cases, the transporter is internalized and recycled via endosomal pathways. The efficiency of release and recycling is critical for maintaining export capacity and cellular homeostasis.
Regulation of Export Activity
In simple terms: The cell controls when and how much it exports based on its needs.
Export activity is tightly regulated at multiple levels, including transcriptional control of transporter genes, post-translational modifications, and interaction with regulatory proteins. For example, in yeast, the expression of drug efflux pumps is induced by stress-responsive transcription factors. In mammalian cells, lysosomal export of metabolites is regulated by mTORC1 signaling and nutrient availability. Dysregulation of these control mechanisms can lead to pathological states such as drug resistance.
Coordination with Vesicle Trafficking
In simple terms: Some substances are packaged into vesicles that fuse with the plasma membrane to release their contents.
In addition to direct transport, export across the plasma membrane can occur via membrane vesicles. Bacteria produce outer membrane vesicles (OMVs) that carry proteins, lipids, and nucleic acids to the extracellular environment. In eukaryotes, exosomes and microvesicles mediate the release of proteins and RNAs. These vesicle-mediated export pathways are distinct from but complementary to transporter-mediated efflux.
Key Genes Involved in GO:0140115 export across plasma membrane
The following genes and proteins are key players in export across plasma membrane, as supported by published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TolC | Outer membrane channel for efflux in Gram-negative bacteria | Model for multidrug efflux and secretion system assembly |
| AcrB | Inner membrane transporter of the AcrAB-TolC efflux pump | Target for efflux pump inhibitors |
| MacB | ABC transporter involved in macrolide export | Studied for antibiotic resistance mechanisms |
| SecYEG | Protein translocase for general secretory pathway | Model for protein export across plasma membrane |
| TatABC | Twin-arginine translocation system for folded protein export | Studied for protein export in bacteria |
| Type I secretion system (T1SS) | One-step secretion of proteins across both membranes | Model for direct protein export |
| Type III secretion system (T3SS) | Injects effector proteins into host cells | Virulence factor export in pathogens |
| Type VI secretion system (T6SS) | Exports toxins into target cells | Bacterial competition and pathogenesis |
| Pdr5 | ABC transporter in yeast for drug efflux | Model for antifungal resistance |
| Snq2 | ABC transporter in yeast for xenobiotic export | Studied for substrate specificity |
| MDR1 (ABCB1) | Human ABC transporter for drug efflux | Cancer multidrug resistance |
| MRP1 (ABCC1) | Human ABC transporter for organic anion export | Drug resistance and inflammation |
| BCRP (ABCG2) | Human ABC transporter for xenobiotic export | Stem cell protection and cancer |
| CFTR | Chloride channel and exporter | Cystic fibrosis and secretion |
| SLC transporters | Solute carriers for metabolite export | Metabolic disorders and drug transport |
| LAMP1 | Lysosomal membrane protein involved in export | Lysosomal storage disorders |
| VAMP7 | SNARE protein for vesicle fusion | Unconventional protein secretion |
How Is export across plasma membrane Regulated?
Export across plasma membrane is regulated at multiple levels. Transcriptional regulation controls the expression of transporter genes in response to environmental cues, such as stress or nutrient availability. Post-translational modifications, including phosphorylation and ubiquitination, modulate transporter activity and stability. In bacteria, two-component systems and small RNAs regulate efflux pump expression. In mammalian cells, mTORC1 signaling promotes lysosomal export of metabolites, while AMPK inhibits it under energy stress. Additionally, membrane lipid composition and membrane potential influence transporter function. Dysregulation of these regulatory networks can lead to drug resistance and disease.
export across plasma membrane and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ABCB1 (MDR1) | Cancer multidrug resistance | Knockout in cancer cell lines to restore drug sensitivity |
| CFTR | Cystic fibrosis | Knock-in of F508del mutation in iPSCs |
| NPC1 | Niemann-Pick disease type C | Knockout in HeLa cells to study lysosomal export |
| SNCA | Parkinson's disease | Overexpression of alpha-synuclein in neurons |
| LAMP1 | Lysosomal storage disorders | Tagged knock-in for live imaging of lysosomal export |
Multidrug Resistance in Cancer
Overexpression of ATP-binding cassette (ABC) transporters such as MDR1 (ABCB1), MRP1 (ABCC1), and BCRP (ABCG2) leads to enhanced export of chemotherapeutic drugs, reducing their intracellular concentration and causing multidrug resistance. This is a major obstacle in cancer treatment and has been linked to poor clinical outcomes.
Bacterial Antibiotic Resistance
In Gram-negative bacteria, efflux pumps such as AcrAB-TolC and MacB export antibiotics, contributing to intrinsic and acquired resistance. The expression of these pumps is often upregulated in clinical isolates, making infections difficult to treat.
Lysosomal Storage Disorders
Defects in lysosomal membrane export of metabolites lead to accumulation of undegraded substrates, causing lysosomal storage disorders such as Niemann-Pick disease type C and cystinosis. Impaired export across the lysosomal membrane is a key pathogenic mechanism.
Neurodegeneration
Dysfunctional export of proteins and metabolites across the plasma membrane has been implicated in neurodegenerative diseases, including Alzheimer's and Parkinson's, where impaired clearance of amyloid-beta and alpha-synuclein contributes to neuronal toxicity.
From export across plasma membrane-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X mediate export of drug Y? | CRISPR knockout of gene X in HeLa cells followed by efflux assay |
| What is the effect of a point mutation in transporter Z on substrate specificity? | Point mutation knock-in in HEK293 cells |
| Can overexpression of ABCB1 confer resistance to a new drug? | Overexpression of ABCB1 in cancer cell lines |
| How does tagging a transporter affect its localization? | Knock-in of GFP tag at endogenous locus |
| What is the role of a regulatory protein in export? | Knockout of regulatory gene in yeast |
| Can CRISPR screen identify novel export genes? | Genome-wide CRISPR knockout library screening |
How to Study the export across plasma membrane Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Efflux assay (flow cytometry) | Export of fluorescent substrates | Screening for efflux pump inhibitors |
| Proteomics (LC-MS/MS) | Exported proteins and metabolites | Identification of secretome |
| Live-cell imaging | Real-time export dynamics | Visualization of vesicle-mediated export |
| CRISPR knockout screen | Genes required for export | Discovery of novel export regulators |
| RNA-seq | Transcriptional changes in export genes | Response to stress or drugs |
| Ribo-seq | Translation of export-related genes | Translational control of efflux pumps |
| Atomic force microscopy | Membrane protein structure | Structural studies of transporters |
Efflux Assays
Efflux assays measure the ability of cells to export fluorescent substrates, such as rhodamine 123 or calcein-AM, using flow cytometry or fluorescence microscopy. These assays are widely used to assess transporter activity and identify inhibitors.
Proteomics and Mass Spectrometry
Proteomic approaches identify proteins secreted into the extracellular medium, providing a global view of export across the plasma membrane. Mass spectrometry can quantify exported metabolites and proteins, revealing novel export pathways.
Live-Cell Imaging
Live-cell imaging with fluorescently tagged transporters or substrates allows real-time visualization of export dynamics. This method is particularly useful for studying vesicle-mediated export and transporter localization.
CRISPR Screens
Genome-wide CRISPR knockout or activation screens can identify genes that regulate export across the plasma membrane. These screens are powerful for discovering novel transporters and regulatory factors.
How CRISPR Can Be Used to Study GO:0140115 export across plasma membrane
Knockout
CRISPR knockout of candidate export genes, such as ABCB1 or TolC, allows researchers to assess their contribution to efflux and resistance. Knockout cell lines can be used in efflux assays to measure loss of transport activity.
Point Mutation
Introducing point mutations in transporter genes via CRISPR can reveal residues critical for substrate binding or ATP hydrolysis. For example, mutations in CFTR can model cystic fibrosis and study export defects.
Knock-in
Knock-in of fluorescent tags or reporter genes at endogenous loci enables real-time tracking of transporter expression and localization. This approach is valuable for studying dynamic regulation of export.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression can increase the expression of export genes to study gain-of-function phenotypes, such as drug resistance. Overexpression models are useful for testing inhibitors.
How EDITGENE Supports export across plasma membrane Research
Researchers studying export across plasma membrane-related genes often need to determine whether a candidate gene is causally involved in transport, resistance, or disease. EDITGENE provides a comprehensive suite of CRISPR services to accelerate this discovery process, from gene knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for export across plasma membrane research.
Frequently Asked Questions About export across plasma membrane
What is export across plasma membrane (GO:0140115)?
Export across plasma membrane is the directed movement of substances from inside a cell across the plasma membrane into the extracellular region, as defined by the Gene Ontology.
What genes are involved in export across plasma membrane?
Key genes include ABC transporters (ABCB1, ABCC1, ABCG2), bacterial efflux pumps (AcrB, TolC), secretion system components (T3SS, T6SS), and yeast transporters (Pdr5, Snq2).
How is export across plasma membrane regulated?
It is regulated transcriptionally, post-translationally, and by signaling pathways such as mTORC1 and stress-responsive factors.
What diseases are associated with defective export across plasma membrane?
Diseases include cancer multidrug resistance, bacterial antibiotic resistance, lysosomal storage disorders, and neurodegeneration.
What methods are used to study export across plasma membrane?
Common methods include efflux assays, proteomics, live-cell imaging, and CRISPR screens.
How can CRISPR be used to study export across plasma membrane?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of export genes and regulatory networks.
What is the role of ABC transporters in export across plasma membrane?
ABC transporters use ATP hydrolysis to pump substrates, including drugs and metabolites, across the plasma membrane.
What is unconventional protein secretion?
Unconventional protein secretion is the export of leaderless proteins across the plasma membrane without passing through the ER-Golgi pathway.
How do bacteria export virulence factors?
Bacteria use dedicated secretion systems, such as type I, III, and VI, to export virulence factors directly across the plasma membrane.
What is the clinical relevance of export across plasma membrane?
It is central to drug resistance, nutrient transport, and intercellular communication, making it a target for therapeutic intervention.
Conclusion
Export across plasma membrane (GO:0140115) is a fundamental biological process that governs the release of diverse molecules from cells. Its dysregulation underlies major human diseases, including cancer and infections. Advances in CRISPR-based models and high-throughput screening are accelerating the discovery of new export mechanisms and therapeutic targets. EDITGENE is committed to supporting this research with state-of-the-art gene editing services.
References
- 1. Nikaido H. 2003. Molecular basis of bacterial outer membrane permeability revisited.. Microbiol Mol Biol Rev 67(4):593-656 PMID: 14665678
- 2. Toyofuku M et al.. 2023. Composition and functions of bacterial membrane vesicles.. Nat Rev Microbiol 21(7):415-430 PMID: 36932221
- 3. Costa TR et al.. 2015. Secretion systems in Gram-negative bacteria: structural and mechanistic insights.. Nat Rev Microbiol 13(6):343-59 PMID: 25978706
- 4. Guérin J et al.. 2021. Protein import and export across the bacterial outer membrane.. Curr Opin Struct Biol 69:55-62 PMID: 33901701
- 5. Nickel W. 2005. Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells.. Traffic 6(8):607-14 PMID: 15998317
- 6. Claus S et al.. 2019. Protein-facilitated transport of hydrophobic molecules across the yeast plasma membrane.. FEBS Lett 593(13):1508-1527 PMID: 31166012
- 7. Rudnik S et al.. 2021. The lysosomal membrane-export of metabolites and beyond.. FEBS J 288(14):4168-4182 PMID: 33067905
- 8. Ri K et al.. 2024. Molecular mechanism of choline and ethanolamine transport in humans.. Nature 630(8016):501-508 PMID: 38778100
